睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300149 睿智医药

已收盘 04-03 15:00:00

{"stockData":{"symbol":"300149","market":"SZ","secType":"STK","nameCN":"睿智医药","latestPrice":12.02,"timestamp":1775199792000,"preClose":12.74,"halted":0,"volume":72000445,"delay":0,"changeRate":-0.0565,"floatShares":475000000,"shares":498000000,"eps":-0.3168,"marketStatus":"已收盘","change":-0.72,"latestTime":"04-03 15:00:00","open":11.92,"high":12.23,"low":11.77,"amount":864000000,"amplitude":0.0361,"askPrice":12.02,"askSize":98,"bidPrice":12.01,"bidSize":850,"shortable":0,"etf":0,"ttmEps":-0.3168,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":12.74,"symbolType":"stock","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":14.01,"lowLimit":11.47,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":497963992,"isCdr":false,"pbRate":5.06,"roa":"--","roe":"0.58%","epsLYR":-0.45,"committee":0.051607,"marketValue":5986000000,"turnoverRate":0.1517,"status":1,"floatMarketCap":5704000000},"requestUrl":"/m/hq/s/300149","defaultTab":"news","newsList":[{"id":"2624527579","title":"睿智医药：截止到2026年3月31日，公司的股东人数为37,007","url":"https://stock-news.laohu8.com/highlight/detail?id=2624527579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624527579?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:48","pubTimestamp":1775116088,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年3月 31日公司的股东总数是多少？谢谢睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年3月31日，公司的股东人数为37,007。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200022857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622388046","title":"睿智医药：截止到2026年3月20日，公司股东人数为35,128","url":"https://stock-news.laohu8.com/highlight/detail?id=2622388046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622388046?lang=zh_cn&edition=full","pubTime":"2026-03-25 11:30","pubTimestamp":1774409449,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止3月20日公司股东人数是多少？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年3月20日，公司股东人数为35,128。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500019205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621746145","title":"股市必读：睿智医药（300149）3月20日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2621746145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621746145?lang=zh_cn&edition=full","pubTime":"2026-03-23 03:17","pubTimestamp":1774207031,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，睿智医药报收于9.62元，下跌3.02%，换手率1.58%，成交量7.49万手，成交额7350.48万元。整包订单转化正稳步加速，预计相关订单确认将从2026年下半年起逐步落地，并在2027年实现稳步拓展。公司将持续关注进展，并按规定履行信息披露义务。其中，享百年健康科技出资335万元，持股67%；安欣投资出资165万元，持股33%。近日，该合资公司已完成工商登记，并取得广州市越秀区市场监督管理局颁发的营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300001307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620578455","title":"睿智医药（300149）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620578455","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620578455?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:29","pubTimestamp":1773998982,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，睿智医药报收于9.62元，较前一交易日下跌3.02%，最新总市值为47.9亿元。该股当日开盘9.92元，最高10.09元，最低9.62元，成交额达7350.48万元，换手率为1.58%。睿智医药于近日披露《2026年第一次临时股东会决议公告》。公告显示，公司于2026年3月19日召开2026年第一次临时股东会，会议采用现场与网络投票结合方式，由董事会召集，董事长WOO SWEE LIAN主持。出席会议股东共242人，代表股份134,340,773股，占总股本26.9780%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620931384","title":"股市必读：睿智医药（300149）3月16日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620931384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620931384?lang=zh_cn&edition=full","pubTime":"2026-03-17 02:12","pubTimestamp":1773684734,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，睿智医药报收于10.2元，上涨0.59%，换手率1.39%，成交量6.59万手，成交额6706.11万元。当日关注点来自交易信息汇总：3月16日主力资金净流入92.72万元，散户资金同步增持。来自机构调研要点：公司联合华东师范大学推出全球首创DC与核苷酸单体微流控合成系统，强化超限智造技术应用。2025年实施限制性股票激励计划，覆盖核心管理与技术骨干，绑定长期发展目标。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700001786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619456898","title":"睿智医药：东吴证券投资者于3月13日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2619456898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619456898?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:11","pubTimestamp":1773652318,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年3月16日睿智医药发布公告称东吴证券于2026年3月13日调研我司。在自动化实验室建设方面，公司与苏州镁伽科技达成深度战略合作，聚焦从概念验证到 PCC的关键研发阶段，共同打造睿智自动化实验室，实现高通量、信息化、一体化的研发能力升级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600023161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0077","BK0216","BK0009","BK0028","BK0183","601555","BK0276","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618183060","title":"睿智医药：公司于2024年底启动两个ADC整包服务项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2618183060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618183060?lang=zh_cn&edition=full","pubTime":"2026-03-12 15:06","pubTimestamp":1773299176,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药03月11日在投资者关系平台上答复投资者关心的问题。感觉公司2025年没有签署新的整包服务订单。公司于2024 年底启动两个 ADC 整包服务项目，整包服务能力已获得客户认可。在持续拓展整包服务业务机会的同时，公司自 2025 年下半年起积极探索通过投资产业基金开展前瞻性布局，围绕创新药产业链挖掘优质项目资源，既能助力产业基金筛选、验证与执行项目，也可为公司整包服务订单储备优质资源，夯实长期业务发展基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200018978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617598848","title":"股市必读：睿智医药(300149)股东户数3.64万户，较上期增加0.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617598848","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617598848?lang=zh_cn&edition=full","pubTime":"2026-03-05 07:58","pubTimestamp":1772668712,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年3月4日收盘，睿智医药报收于9.84元，下跌1.2%，换手率1.54%，成交量7.32万手，成交额7234.42万元。来自交易信息汇总：3月4日主力资金净流出479.27万元，游资资金净流入596.9万元。股东户数变动近日睿智医药披露，截至2026年2月27日公司股东户数为3.64万户，较2月13日增加2.0户，增幅为0.01%。户均持股数量由上期的1.37万股减少至1.37万股，户均持股市值为14.8万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260305/32045362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616584585","title":"睿智医药：截至2026年2月27日，公司股东人数为36,371人","url":"https://stock-news.laohu8.com/highlight/detail?id=2616584585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616584585?lang=zh_cn&edition=full","pubTime":"2026-03-04 15:15","pubTimestamp":1772608525,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)03月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2月底股东人数有多少睿智医药回复：您好，感谢您对公司的关注。截至2026年2月27日，公司股东人数为36,371人。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400020886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614870007","title":"睿智医药：目前公司定增项目仍在审批中","url":"https://stock-news.laohu8.com/highlight/detail?id=2614870007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614870007?lang=zh_cn&edition=full","pubTime":"2026-02-27 11:33","pubTimestamp":1772163190,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)02月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司定增方案为何迟迟没有批复?如果证监会没有批复，公司有何应对方案?睿智医药回复：尊敬的投资者，您好！目前公司定增项目仍在审批中，后续还需深交所审核通过及获得中国证监会同意注册后方可实施。公司也在持续关注进展，并将严格按照相关法律法规的要求及时履行信息披露义务。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700016323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614251727","title":"睿智医药：截至2026年2月13日，公司股东人数为36,369人","url":"https://stock-news.laohu8.com/highlight/detail?id=2614251727","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614251727?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:06","pubTimestamp":1771981568,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截日股东人数是多少？睿智医药回复：您好，感谢您对公司的关注。截至2026年2月13日，公司股东人数为36,369人。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500006350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614727252","title":"睿智医药：截至2026年2月13日，公司股东人数为36,369人","url":"https://stock-news.laohu8.com/highlight/detail?id=2614727252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614727252?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:06","pubTimestamp":1771981566,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到2月20日（2月13日收盘）公司的股东人数是多少？谢谢睿智医药回复：您好，感谢您对公司的关注。截至2026年2月13日，公司股东人数为36,369人。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500006347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613739236","title":"股市必读：睿智医药(300149)股东户数3.7万户，较上期减少1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613739236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613739236?lang=zh_cn&edition=full","pubTime":"2026-02-24 02:06","pubTimestamp":1771869976,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，睿智医药报收于10.99元，下跌0.99%，换手率1.41%，成交量6.71万手，成交额7434.48万元。交易信息汇总资金流向2月13日主力资金净流出545.89万元，占总成交额7.34%；游资资金净流出112.9万元，占总成交额1.52%；散户资金净流入658.79万元，占总成交额8.86%。股本股东变化股东户数变动近日睿智医药披露，截至2026年2月10日公司股东户数为3.7万户，较1月30日减少376.0户，减幅为1.0%。户均持股数量由上期的1.33万股增加至1.34万股，户均持股市值为15.17万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400007410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611270185","title":"睿智医药：截止至2026年2月10日，公司股东人数为37,038人","url":"https://stock-news.laohu8.com/highlight/detail?id=2611270185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611270185?lang=zh_cn&edition=full","pubTime":"2026-02-13 11:33","pubTimestamp":1770953633,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年2月10日收盘公司股东人数为多少，谢谢！睿智医药回复：您好，感谢对公司的关注。截止至2026年2月10日，公司股东人数为37,038人。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300014783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610633071","title":"睿智医药(300149)1月30日股东户数3.74万户，较上期减少0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633071","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610633071?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:27","pubTimestamp":1770629272,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年1月30日公司股东户数为3.74万户，较1月20日减少227.0户，减幅为0.6%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至1月30日，医疗服务行业平均股东户数为4.63万户。从股价来看，2026年1月20日至2026年1月30日，睿智医药区间跌幅为3.33%，在此期间股东户数减少227.0户，减幅为0.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900022196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608336547","title":"睿智医药：截至1月30日，公司的股东人数为37,414人","url":"https://stock-news.laohu8.com/highlight/detail?id=2608336547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608336547?lang=zh_cn&edition=full","pubTime":"2026-02-04 11:33","pubTimestamp":1770176036,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到一月底股东人数是多少？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截至1月30日，公司的股东人数为37,414人。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400016151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608896758","title":"股市必读：睿智医药（300149）预计2025年全年扣非后净利润亏损250万元至375万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608896758","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608896758?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:26","pubTimestamp":1769973973,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，睿智医药报收于10.44元，下跌2.34%，换手率2.42%，成交量11.51万手，成交额1.21亿元。来自：2025年度非经常性损益影响金额为1,480万元至2,220万元，主要来源于出售合营公司投资收益及政府补助。业绩披露要点业绩预告睿智医药发布业绩预告，预计2025年全年扣非后净利润亏损250万元至375万元。非经常性损益影响约为1,480.00万元至2,220.00万元，主要为出售合营公司投资收益及政府补助。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607705344","title":"股市必读：睿智医药(300149)股东户数3.76万户，较上期减少3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607705344","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607705344?lang=zh_cn&edition=full","pubTime":"2026-01-30 03:43","pubTimestamp":1769715790,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，睿智医药报收于10.69元，下跌0.28%，换手率2.48%，成交量11.78万手，成交额1.26亿元。股本股东变化股东户数变动近日睿智医药披露，截至2026年1月20日公司股东户数为3.76万户，较1月10日减少1393.0户，减幅为3.57%。户均持股数量由上期的1.28万股增加至1.32万股，户均持股市值为14.29万元。董秘最新回复投资者： 董秘您好，请问公司到1月20日的股东人数，谢谢董秘： 尊敬的投资者，您好！截至1月20日，公司的股东人数为37,641人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000004081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607590701","title":"睿智医药：公司在股权激励计划中所设定的业绩目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2607590701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607590701?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:21","pubTimestamp":1769674870,"startTime":"0","endTime":"0","summary":"投资者提问：公司股权激励计划2027年营收25亿以上，利润2个亿。据投资者会议记录，胡瑞连董事长说长远目标是达到全世界临床前CRO业务的百分之一。感谢对公司的关注。公司在股权激励计划中所设定的业绩目标，是基于对公司过往经营积淀、目前运营状况、核心研发平台能力、市场化拓展策略以及内部运营效率提升等多方面因素的综合评估，经审慎论证后确定的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900025831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607749799","title":"股市必读：1月28日睿智医药现1笔折价17.63%的大宗交易 合计成交247.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607749799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607749799?lang=zh_cn&edition=full","pubTime":"2026-01-29 01:56","pubTimestamp":1769622972,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，睿智医药报收于10.72元，下跌2.81%，换手率2.46%，成交量11.67万手，成交额1.26亿元。来自交易信息汇总：睿智医药当日出现一笔折价17.63%的大宗交易，合计成交247.06万元，引发市场关注。交易信息汇总资金流向1月28日主力资金净流出1064.33万元；游资资金净流入700.34万元；散户资金净流入364.0万元。大宗交易1月28日睿智医药现1笔折价17.63%的大宗交易，合计成交247.06万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900001132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775281512730,"stockEarnings":[{"period":"1week","weight":0.1704},{"period":"1month","weight":0.2215},{"period":"3month","weight":0.2573},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.7807},{"period":"ytd","weight":0.2573}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"睿智医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"37007人(较上一季度增加5.35%)","perCapita":"12823股","listingDate":"2010-12-22","address":"广东省江门市江海区胜利南路164号","registeredCapital":"49796万元","survey":"　　睿智医药科技股份有限公司的主营业务是提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务。公司的主要产品是化学业务、药效药动业务、大分子业务。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿智医药,300149,睿智医药股票,睿智医药股票老虎,睿智医药股票老虎国际,睿智医药行情,睿智医药股票行情,睿智医药股价,睿智医药股市,睿智医药股票价格,睿智医药股票交易,睿智医药股票购买,睿智医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}